The prevalence of kidney disease has been increasing in Japan, with it now affecting one in eight adults, but developing effective treatment remains a challenge.
Novo Nordisk inks pact for discovery of ‘molecular glues’ in deal worth as much as $1.46B
Novo Nordisk has inked an up to $1.46 billion deal with the biotech Neomorph to develop “molecular glues,” a field that’s seeing a flurry of
February 27, 2024